Blueshift Asset Management, LLC Novavax Inc Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $674,928 - $1.03 Million	-3,796 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $32,549 - $69,313	-269 Reduced 6.62%	3,796 $806,000
Q1 2021 May 06, 2021	SELL	$112.98 - $319.93 $559,363 - $1.58 Million	-4,951 Reduced 54.91%	4,065 $737,000
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $287,243 - $508,896	3,648 Added 67.96%	9,016 $1.01 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $426,433 - $958,241	5,368 New	5,368 $582,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.